(MedPage Today) — WASHINGTON — An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.
At week 24, the combined response of alanine…
Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118381
Author :
Publish date : 2025-11-09 23:00:00
Copyright for syndicated content belongs to the linked Source.
